Legal & General Group
AMPH icon

Legal & General Group’s Amphastar Pharmaceuticals AMPH Stock Holding History

Legal & General Group’s Portfolio AMPH Stock Details AMPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.59M Sell
80,916
-9,814
-11% -$240K ﹤0.01% 2004
2025
Q4 		$2.43M Sell
90,730
-6,884
-7% -$177K ﹤0.01% 1895
2025
Q3 		$2.6M Sell
97,614
-3,540
-3% -$91.4K ﹤0.01% 1876
2025
Q2 		$2.32M Sell
101,154
-422
-0.4% -$10.5K ﹤0.01% 1912
2025
Q1 		$2.94M Sell
101,576
-2,165
-2% -$69.1K ﹤0.01% 1772
2024
Q4 		$3.85M Sell
103,741
-582
-0.6% -$26.6K ﹤0.01% 1703
2024
Q3 		$5.06M Sell
104,323
-1,526
-1% -$67K ﹤0.01% 1571
2024
Q2 		$4.23M Sell
105,849
-1,478
-1% -$61.2K ﹤0.01% 1607
2024
Q1 		$4.71M Buy
107,327
+241
+0.2% +$12.4K ﹤0.01% 1548
2023
Q4 		$6.62M Buy
107,086
+136
+0.1% +$7.14K ﹤0.01% 1373
2023
Q3 		$4.92M Sell
106,950
-2,475
-2% -$135K ﹤0.01% 1446
2023
Q2 		$6.29M Buy
109,425
+14,663
+15% +$650K ﹤0.01% 1330
2023
Q1 		$3.55M Buy
94,762
+2,172
+2% +$71.2K ﹤0.01% 1601
2022
Q4 		$2.59M Buy
92,590
+1,150
+1% +$33.4K ﹤0.01% 1751
2022
Q3 		$2.57M Buy
91,440
+2,206
+2% +$72K ﹤0.01% 1729
2022
Q2 		$3.1M Buy
89,234
+2,043
+2% +$72.9K ﹤0.01% 1655
2022
Q1 		$3.13M Sell
87,191
-684
-0.8% -$19.4K ﹤0.01% 1781
2021
Q4 		$2.05M Buy
87,875
+2,606
+3% +$53.3K ﹤0.01% 2025
2021
Q3 		$1.62M Buy
85,269
+8,668
+11% +$170K ﹤0.01% 2109
2021
Q2 		$1.54M Sell
76,601
-24,806
-24% -$467K ﹤0.01% 2084
2021
Q1 		$1.86M Buy
101,407
+546
+0.5% +$10.2K ﹤0.01% 2006
2020
Q4 		$2.03M Buy
100,861
+701
+0.7% +$13.6K ﹤0.01% 1889
2020
Q3 		$1.88M Buy
100,160
+6,776
+7% +$136K ﹤0.01% 1785
2020
Q2 		$2.1M Buy
93,384
+6,486
+7% +$119K ﹤0.01% 1715
2020
Q1 		$1.29M Buy
86,898
+161
+0.2% +$2.8K ﹤0.01% 1763
2019
Q4 		$1.67M Buy
86,737
+5,326
+7% +$102K ﹤0.01% 1881
2019
Q3 		$1.61M Sell
81,411
-1,873
-2% -$39K ﹤0.01% 1806
2019
Q2 		$1.76M Buy
83,284
+1,400
+2% +$29.3K ﹤0.01% 1748
2019
Q1 		$1.67M Buy
81,884
+7,623
+10% +$171K ﹤0.01% 1765
2018
Q4 		$1.48M Buy
74,261
+37
+0% +$729 ﹤0.01% 1725
2018
Q3 		$1.43M Buy
74,224
+2,568
+4% +$45.8K ﹤0.01% 1838
2018
Q2 		$1.1M Buy
71,656
+5,976
+9% +$104K ﹤0.01% 1903
2018
Q1 		$1.23M Buy
65,680
+94
+0.1% +$1.77K ﹤0.01% 1824
2017
Q4 		$1.26M Sell
65,586
-226
-0.3% -$4.22K ﹤0.01% 1808
2017
Q3 		$1.18M Buy
65,812
+911
+1% +$15K ﹤0.01% 1795
2017
Q2 		$1.16M Buy
64,901
+5,927
+10% +$94K ﹤0.01% 1775
2017
Q1 		$856K Sell
58,974
-154
-0.3% -$2.42K ﹤0.01% 1848
2016
Q4 		$1.09M Buy
59,128
+29,479
+99% +$573K ﹤0.01% 1705
2016
Q3 		$561K Buy
29,649
+23,954
+421% +$435K ﹤0.01% 1640
2016
Q2 		$91K Hold
5,695
– – ﹤0.01% 2147
2016
Q1 		$69K Hold
5,695
– – ﹤0.01% 2264
2015
Q4 		$81K Hold
5,695
– – ﹤0.01% 2201
2015
Q3 		$63K Hold
5,695
– – ﹤0.01% 2319
2015
Q2 		$99K Buy
+5,695
New +$88.8K ﹤0.01% 2118

Other funds holding AMPH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $123B AUM 34.51% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $12.2B AUM 12.45% 1-Year Est. Return

Legal & General Group's AMPH Position: Q1 2026 in Review

Legal & General Group reduced its Amphastar Pharmaceuticals (AMPH) stake by 11% in Q1 2026, selling an estimated $240K and leaving 80,916 shares worth $1.59M. The position accounts for ﹤0.01% of the portfolio, ranked #2004.

Legal & General Group first reported a position in AMPH in Q2 2015 and has held it in 44 quarters since. The position peaked at $6.62M in Q4 2023. 215 funds tracked by Wall St. Rank hold AMPH as of Q1 2026.

  • Legal & General Group held 80,916 shares of Amphastar Pharmaceuticals worth $1.59M as of Q1 2026.
  • Legal & General Group sold 9,814 Amphastar Pharmaceuticals shares in Q1 2026, an estimated $240K.
  • Amphastar Pharmaceuticals made up ﹤0.01% of Legal & General Group's portfolio in Q1 2026, its #2004 holding.
  • Legal & General Group first reported a position in Amphastar Pharmaceuticals in Q2 2015 and has held it in 44 quarters since.
  • Legal & General Group's Amphastar Pharmaceuticals position peaked at $6.62M in Q4 2023.
  • 215 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q1 2026.

Based on Legal & General Group's 13F filing for Q1 2026, filed 8 May 2026.